TrivarX (TrivarX) Institutional Ownership : 7.84% (As of Jun. 11, 2024)

View and export this data going back to 2017. Start your Free Trial

What is TrivarX Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, TrivarX's institutional ownership is 7.84%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, TrivarX's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, TrivarX's Float Percentage Of Total Shares Outstanding is 0.00%.

TrivarX Institutional Ownership Historical Data

The historical data trend for TrivarX's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Institutional Ownership Chart

TrivarX Historical Data

The historical data trend for TrivarX can be seen below:

	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	8.48	8.48	9.56	9.52	9.49	9.49	9.49	9.52	9.48	7.84

TrivarX Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

TrivarX (TrivarX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

TRI:Australia

Address

647 Beaufort Street, Mount Lawley, WA, AUS, 6050

Website

https://www.medibio.com.au

TrivarX Ltd Formerly Medibio Ltd is a medical technology company. The principal activity of the company is conducting clinical research, product development, and early-stage commercialization of mental health technology using objective biomarkers to assist in the screening, diagnosing monitoring, and management of depression and other mental health conditions. It serves both consumer and healthcare provider markets. In addition, the company offers various psychological services to customers in Australia. The company operates in two geographical markets; Australia and the United States. The company has one operating segment, being the research, development, and commercialization of its Software as a Service product.